VaxGen: Clinical Trials

2 trials sponsored by VaxGen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 11Unknown 1

Follow VaxGen: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers
LC16m8 Smallpox Vaccine - Smallpox
Phase 1 / Phase 2UnknownVaxGen1502004-10-012007-01-15
Trial of rPA-102 Vaccine in Healthy Adult Volunteers
rPA102 - Anthrax
Phase 2CompletedVaxGen4802004-04-012006-01-12

Conditions studied

Anthrax (1)  ·  Smallpox (1)

Interventions

smallpox vaccine LC16m8 (1)

Countries

United States (2)

Top investigators

Marc Gurwith, MD, JD (1)

Results publications

PMID 21921208